2 recruiting, 1 not yet recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 2, Not yet recruiting 1 |
Follow Type 1 Diabetes (T1D): new trials by email Literature Review of Type 1 Diabetes (T1D) trials Research Report on Type 1 Diabetes (T1D)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CKM For Safe Use of SGLT2i in Type 1 Diabetes Sotagliflozin Low Dose, Sotagliflozin High Dose, Dual Continuous Glucose and Ketone Monitor - Type 1 Diabetes (T1D) | Phase 3 | Not yet recruiting | University of California, San Diego | 52 | 2027-04-01 | 2026-11-04 |
| PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study SAB-142, Placebo - Type 1 Diabetes (T1D) | Phase 3 | Recruiting | University of Florida | 108 | 2026-11-10 | 2026-11-16 |
| GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes Tirzepatide - Type 1 Diabetes (T1D) | Phase 3 | Recruiting | University of Bern | 42 | 2025-02-14 | 2026-01-26 |
Autoimmune Diseases (3) · Diabetes Mellitus (3) · Endocrine System Diseases (3) · Glucose Metabolism Disorders (3) · Immune System Diseases (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3)
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (1) · Tirzepatide (1)
University of Bern (1) · University of California, San Diego (1) · University of Florida (1)
United States (2) · Switzerland (1)
Thomas Zueger, PD Dr. med. (1)
2025 (1), U01DK143381 (1)